Oncology Clinical Operations Asset Lead, Director

At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people over the next 10 years. R&D is committed to discovering and delivering transformational vaccines and medicines to prevent and change the course of disease. Science and technology are coming together in a way they never have before, and we have strong tech-enabled capabilities that allow us to build a deeper understanding of the patient, human biology and disease mechanisms, and transform medical discovery.  We are revolutionising the way we do R&D. We’re uniting science, technology and talent to get ahead of disease together.

The Clinical Operations Asset Lead represents all Clinical Operations functions at the asset level and is accountable for developing the operational strategy and delivery plan to execute the scientific strategy for an asset and associated studies, working in partnership with clinical / biostats / clinical supplies and the functional subject matter experts to ensure informed asset decision-making from the operational, scientific and data perspectives

Key Responsibilities:

• Contribute to the development of the Clinical Development Plan and Integrated Evidence Plan

• Oversee delivery and data quality of all studies for the asset

• Delivery of operational plan for the asset which includes:

  • Generation of delivery scenarios to support governance board decisions.

  • Accountability for study level planning, feasibility and conduct. 

  • Leadership of innovative approaches to study execution.

  • Accountability for study budgets

• Lead resourcing discussions and be accountable for the final strategy (in vs outsourcing) for the asset, and studies, in accordance with the resourcing strategy & principles

• Contribute to asset level risk register, lead asset level mitigation plans for relevant delivery or quality issues, and oversight of study level risks

Capabilities:

• Demonstrates conceptual, analytical and strategic thinking to innovative approaches to clinical delivery, leverage external technology and networks and build internal capability

• Ability to translate strategic concepts, scientific requirements, stakeholder feedback and expectations into cohesive actions for the Asset team

• Innovative and change adept whilst identifying and embracing risks as opportunities

• Ability to establish and build internal and external relationships at all levels in a highly dynamic and matrixed environment, demonstrating conflict management and negotiation skills

• Partnering skills with key role such as clinical science, biostatistics and other subject matter experts (SME) at asset level to articulate and champion key decisions and strategy

• Excellent leadership skills building and managing matrixed teams, promoting motivation and empowerment of others to accomplish individual, team and organizational objectives

• Strong influencing and stakeholder management skills at all levels of the organization.

• Strong communication skills appropriate to the target audience, promoting effective decision-making

• Leadership style sensitive to different cultures and experience levels in a matrix environment to ensure appropriate asset operational delivery and optimally motivate individuals to reach their potential

Basic Qualifications

• Bachelor’s in general science or Life/Health related Science Degree.

• Extensive years of significant experience in managing clinical research projects.

• Several years of oncology clinical operations experience in a global role

• Above study (project level) leadership experience

• Leadership experience with senior stakeholder management.

• Experience in study and matrix management is required.

• Phase 1 and 2 Clinical Study experience

Preferred Qualifications

• Experience delivering registrational oncology studies from start to finish

• Experience leading platform studies

LI-GSK*

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and dat